A clinical trial to study the efficacy of Rasa chendhuram internal drug for symmetrical multiple joints(Rheumatoid arthritis)

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2017
INTERVENTION: Intervention1: 1.Rasa chendhuram(Int) 2.Roga sanjeevi thylam(Ext): 1.20Patients treated with rasa chendhuram (int)‐65mg twice daily with honey and Roga Sanjeevi thylam (ext) application for48days Intervention2: 1.Rasa chendhuram(Int). 2.Roga sanjeevi thylam (Ext). 3.Ottradam: 20Patients treated with Rasa chendhuram (int)‐65mg twice daily with honey and Roga Sanjeevi thylam(ext) application and ottradam for 48days Control Intervention1: Nil: Nil CONDITION: Patients having arthritis of three or more joints pain and swelling in the distal interphalangeal joints morning stiffness patients having RAfactor positive Anti ccp positive and aneamia PRIMARY OUTCOME: Reducing the pain and morning stiffness‐‐‐‐‐‐Timepoint: 12 Months SECONDARY OUTCOME: To study the safety profile of the drug before and after treatment.‐‐‐‐‐‐Timepoint: 12 Months INCLUSION CRITERIA: Age 18‐60 Years Both male and female Morning stiffness Pain and swelling in the distal interphalangeal Joints. RA Factor positive ANTI CCP POSITIVE ARTHRITIS OF MORE THAN THREE JOINTS
Epistemonikos ID: 32bd6a38cb3c4c9f17fbaf0bfefe503c42cfd62d
First added on: Mar 23, 2022